cbdMD Inc. (YCBD): Healthcare sector is gaining shares


cbdMD Inc. (AMEX:YCBD) changes shares on Friday trading session, with a change of 22.58% or $0.35 shares. The trading starts at $1.52 and closed at $1.55 throughout the day. The trading session low price was $1.50 and day high was $2.00 on Friday, June 19. After the session, the Healthcare sector daily volume shifted to 4.29 million while its average volume is 1.83M. In other hand, the YCBD market cap reached to $90.61M. While, its current target price is $1.90 according to WSJ.

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 21.79% and up 22.58% for month. Its quarterly performance was 144.66% above, while its half year performance is down -38.91%. YCBD yearly performance stood at negative -69.84% and fall -15.93% for year-to-date. Current recommendation for cbdMD Inc. is 2.30.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. YCBD EPS (TTM) for 12-month is 0.27. EPS for this year is -747.80%, while for the next year its value is 0.00. Its EPS Q/Q reached 112.70%.

Let’s take a look on the analyst recommendations on YCBD for the current month and previous month. For the current month, 2 of 3 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 1 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $1.80-$8.00. Average target price for YCBD was reached at $4.27.

Blackrock Inc., Vanguard Group, Inc. (The) and Zeke Capital Advisors LLC are the top three holders in cbdMD Inc. (YCBD) stock. On Mar 30, 2020, Blackrock Inc. has 1.46 million shares which valued 1.36 million. On Mar 30, 2020, Vanguard Group, Inc. (The) owned 1.3 million shares which valued at 1.21 million. On Mar 30, 2020, Zeke Capital Advisors LLC has a total of 0.7 million shares which valued at 0.65 million. In the end, Zeke Capital Advisors LLC have 1.36% shares outstanding of cbdMD Inc. (YCBD) on Mar 30, 2020. The insider ownership moved to 0.90% and institutional holding shifted to 14.30%.

The company posted an EPS (TTM) of 0.27. According to the most recent quarter report on (Jun 2020), 2 analysts estimated an average EPS of -0.03, while -1.19 EPS posted a year ago period. Analyst Estimated EPS for YCBD published in the report was -0.05–0.02 during the same period. Comparing with last year, the average estimated EPS was -1.19 which is lower than 0.42 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for YCBD fall -11.14% for period of 200 days. SMA for 50 days was 58.27% which is showing green signal, while SMA-20 was 21.60%. The moving average value for cbdMD Inc. (YCBD) is 1.3779 and 1.3770 for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in YCBD stock. On Mar 09, Ghiloni Peter J., Director, bought 25,000 trading shares at the cost of $0.75, which valued at 18720.0. On Jan 27, Elliott Mark S, CFO & COO, bought 5,000 shares at the cost of $1.06, with total shares of 51,680. On Jan 14, Coffman Raymond Scott, CO-CEO, bought 125,000 shares at the cost of 1.00. After this transaction, Coffman Raymond Scott total shares reached to 12,559,000 which valued at 0.13 million.